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MetastasisKorean Citrus aurantium L. has long been used as a traditional medicine for the treatment of
various cancers such as those of lung and prostat. C. aurantium L. has been reported to have
anti-metastasis properties in in vitro experiments. However, the anti-metastasis effect of C.
aurantium L. in vivo is not well understood. This study investigated the anti-metastatic
effect of flavonoids isolated from Korean C. aurantium L. using high-performance liquid
chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) in NOD/SCID
mice. PKH-26 staining and immunohistochemical analyses indicated that flavonoids pre-
vented cancer cell infiltration and localization to the lung. Also, flavonoids induced cancer
cell apoptosis through the regulation of the apoptosis related protein cleaved caspase-3 and
p-p53. In vitro results also show that flavonoids inhibited A549 cells metastasis and induced
apoptosis. Moreover, proteomic analysis indicated comparable down-regulation of the
Ddx3x and ANP43B proteins with control group after treatment with flavonoids. These
results provide scientific support for the use of flavonoids isolated from C. aurantium L.
for the treatment of human lung cancer.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Lung cancer is the most frequently diagnosed cancer,
responsible for almost 1.38 million deaths annually world-wide (Ferlay et al., 2010). Non-Small-Cell Lung Cancer
(NSCLC) accounts for more than 80% of all lung cancer pa-
tients. NSCLC is a highly aggressive and metastatic cancer
with limited treatment options. Most cases present locallyty, Gazwa,
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(Fong et al., 2009). The most commonly used therapies for
NSCLC are chemotherapy, radiation and surgical treatment.
In 2010, there were 15,623 lung cancer cases in Korea,
accounting for 31.3% of all cancer death rates in the coun-
try. Concerning lung cancer in Korea, it is notable this can-
cer is the fourth most prevalent yet survival is the least.
Although the survival rate for lung cancer has increased
gradually, more efficient therapeutic agents are needed to
improve survival rate.
Citrus aurantium is a citrus tree that grows to 9 m (29 ft)
by 6 m (19 ft), with scented white flowers, that belongs to
the Rutaceae family of the order Sapindales. It is distributed
widely in tropical and subtropical southeast regions of the
world. The immature peels of citrus fruit are used as a tra-
ditional medicine to treat various diseases; they display
anti-emetic, anti-tussive, carminative, diaphoretic, digestive,
and expectorant activities (Fugh-Berman & Myers, 2004; Li,
Wang, Guo, Zhao, & Ho, 2014). Citrus species including C.
aurantium L. contain a wide range of active ingredients
and consist of several components including limonoid and
flavonoids (Jung et al., 2007). These flavonoids contained
in C. aurantium L. regulate the inflammatory response, car-
diovascular diseases, and carcinogenesis through a variety
of mechanisms (Xiao et al., 2011; Manthey, Grohmann, &
Guthrie, 2001). Recent studies have also reported that flavo-
noids prevent the proliferation of various cancer cell lines
and alter cell cycle behavior (Lee et al., 2012; Kim,
Jayaprakasha, Vikram, & Patil, 2012).
Metastasis is a complex and multiple processes that in-
clude detachment from the primary tumor site, infiltration
to the stromal region, and tumor cell proliferation (Steeg,
2006). The fluorescent dye PKH-26 is a lipophilic marker that
inserts into the membranes of viable cells. The dye cannot
be transferred from cell-to-cell and so effectively labels the
membrane of individual cells (Horan & Slezak, 1989). The la-
beled cells can be tracked in vivo tracking, enabling the effi-
cient identification of cell distribution in the body. When a
PKH-26-labeled cell divides, the fluorescence intensity is re-
duced by half, which permits the objective observation of
cell-to-cell interaction. PKH-26 cell fluorescence persists for
a long time in vivo. Thus, PKH-26 has been successfully used
to trace the metastasis of tumor cells (Yamagata & Kumagai,
2000).
The lung, in particular the regions where gas is exchanged,
is comprised of alveolar ducts and millions of alveoli. Micro-
scopically, alveoli consist of polyhedral air spaces that are
intimately related with blood vessels. This structure is lined
by two types of simple epithelial cells: squamous and cuboi-
dal epithelial cells. Pulmonary capillaries are the first filters
encountered by tumor emboli released into the vena cava;
secondary neoplasia in the lung is relatively common. A typ-
ical secondary lung cancer is evident at multiple sites scat-
tered throughout the lung lobes.
This study was undertaken to confirm the effects of
flavonoids isolated from C. aurantium L. on cancer cell inva-
sion, metastasis and apoptosis. The study is the first to
investigate the possible anti-cancer behavior of flavonoids
and to determine the mechanism of apoptosis related pro-
tein expression.2. Materials and methods2.1. Chemicals
RPMI1640 medium was purchased from Hyclone (Logan, UT,
USA). Antibiotics (streptomycin/penicillin) and fetal bovine
serum (FBS) were obtained from Gibco (Grand Island, NY,
USA). PKH-26 staining kit and silver staining materials were
purchased from Sigma–Aldrich (St. Louis, MO, USA). Antibod-
ies to p-p53, cleaved caspase-3, BAX and b-actin were ob-
tained from Millipore (Billerica, MA, USA).
2.2. Isolation of flavonoids from Korean C. aurantium L
Fruits of Korean C. aurantium L. were obtained from the Citrus
Genetic Resources Bank, Jeju National University. The fruits
were scrupulously washed with water and stored at 70 C
until extraction (Animal Bio-Resource Bank, Korea). The fruit
peel was finely ground (1–2 mm) after lyophilisation in a PVTE-
D50A apparatus (Ilsin BioBase, Yangju, Korea). The powder of
the fruit peel (1500 g) was extracted using a PT-MR 2100 appa-
ratus (Kinematica, Lucerne, Switzerland) in 3 L of 70% aqueous
methanol for 24 h. After seven extraction cycles, the extracts
were combined and filtered using a Buchner funnel. The fil-
trate was concentrated to 140 mL using an Eyela NVC-2100 ro-
tary evaporator (Tokyo Rikakikai, Tokyo, Japan). 25 mL ofwater
and 3 g NaOH were added to the concentrate, which was ex-
tracted with 200 mL ethyl acetate. After three extraction cy-
cles, the organic layer was neutralized with brine and dried
over anhydrous MgSO4 to yield 0.6 g of flavonoid components
(The extract was completely dried using vacuum evaporator).
High performance liquid chromatographic (HPLC) analysis
was carried out using a model 1100 series LC system (Agilent
Technologies, Palo Alto, CA, USA). Chromatographic separation
wasperformedona4.6 · 250 mm,5 lmZorbaxStableBondAna-
lytical SB-C18 column (4.6 · 250 mm, 5 lm, Agilent Technolo-
gies). The binary solvent system consisted of 0.1% aqueous
formic acid (A) and methanol/acetonitrile (B) in a 1:1 ratio. The
elutionwasperformedbya lineargradient from0%to25%Bover
10 min, from 40% to 70% B over 10min, followed by 30min of
isocratic elution, decreased from 40% to 25% B over 5 min, and
followed by 10min of isocratic elution. The flow rate was
0.5 mL/min with a column temperature of 35 C. Chromato-
graphic datawere collected andmanipulated using a ChemSta-
tion,Rev.B.0301. Spectral datawere collected (200–400 nm, 2-nm
resolution) for theentire run, and theflavonoidswerequantified
by extracting the chromatograms at 280 nm (Fig. 1). All flava-
nones and flavones were quantified using the external calibra-
tion curves of hesperetin and nobiletin, respectively.
Tandem mass spectrometry (MS/MS) experiments were
conducted using a 3200 QTRAP LC–MS/MS system (Applied
Biosystems, Foster City, CA, USA) with a Turbo V source and
a Turbo Ion Spray probe. The mass spectrometer was man-
aged in the positive mode with selected ion monitoring
(SIM). BioAnalyst, version 1.4.2 software (AB SCIEX, Fra-
mingham, MA, USA) and the analyst software, version 1.4.2,
was used for instrumental control and data acquisition,
respectively. Nitrogen at a pressure of 45 psi was used as a
nebulizing and drying gas. The electron spray voltage was
set at 5.2 kV and the source temperature at 500 C. The mass
Fig. 1 – HPLC profile at 280 nm of flavonoids identified in Korea Citrus aurantium L. (1) naringin, (2) hesperidin, (3) poncirin, (4)
isosinnesetin, (5) hexamethoxyflavone, (6) sinestin, (7) hexamethoxyflavone, (8) tetramthvl-o-isoscutellaein, (9) nobiletin,
(10) heptamethoxyflavone, (11) 3-Hydoxynobiletin, (12) tangeretin, (13) hydroxypentamethoxyflavone, (14)
hexamethoxyflavone.
J O U R N A L O F F U N C T I O N A L F O O D S 7 ( 2 0 1 4 ) 2 8 7 –2 9 7 289spectra were recorded between m/z 100 and m/z 1000 with a
step size of 0.06 amu.
2.3. Labeling A549 cells with PKH-26 marker
A549 human lung carcinoma cells (Human embryonic fibro-
blast, lung-derived cell line) obtained from the Korean Cell
Line Bank (KCLB, Seoul, Korea) were cultured in RPMI 1640
medium supplemented with 10% FBS and 1% penicillin/strep-
tomycin (P–S) in a 5% CO2 atmosphere at 37 C. A549 cells
were washed with phosphate buffered saline (PBS) and sus-
pended in Diluent C (3 mL), which was included as part of
the PKH-26 kit. PKH-26 (2 mM, 50 lL) was diluted in 3 mL of
Diluent C. The dilute PKH-26 was added to the cell suspension
and gently mixed. Staining was performed at room tempera-
ture in dark room for 5 min. PBS supplemented with 1% bo-
vine serum albumin (BSA) (10 mL) was added to terminate
the labeling reaction and the suspension was gently mixed.
Cells were washed three times with PBS.
2.4. In vivo experiment design
NOD.CB17-Prkdcscid/ARC (Severe Combined Immunodeficient,
Non-Obese Diabetic) mice were purchased from Central Lab.
Animal (Seoul, Korea). All experiments were performed in
accordance with the experimental animal guidelines of
Gyeong-Sang National University. Six-week-old NOD/SCID
mice were divided into three groups: negative control, posi-
tive control with tail vein injection of PKH-26 labeled cells,
and the experimental group. Mice in the third group received
an intraperiteonal injection of flavonoids in the tail veinfollowing tail vein injection of PKH-26 labeled cells. Viable
A549 cells (1.0 · 106) in 500 mL saline were injected via the tail
vein. Flavonoids were injected intraperitoneally twice weekly
4 days following injection of the A549 cells. After 5 weeks, all
mice were anesthetized with a zolazepam-HCl/tiletamin-HCl
mixture (100 mg/kg) and euthanized by cervical dislocation.
Lungs were collected and directly washed with cold PBS. Half
of each lung was fixed in 4% neutral formaldehyde and the
other half was stored 70 C until further analysis.
2.5. Hematoxylin and eosin staining
Hematoxylin and eosin (H–E) staining was performed to study
histopathological changes. Lung samples 5 lm in thickness
were prepared from paraffin embedded samples. Sections
were incubated for 10 min in xylene (10 and 10 min in each)
followed by dehydration in an increasing series of ethanol
concentrations (70%, 95%, and 100%; 5 min in each). The sec-
tions were rinsed in water before being placed in Harris
hematoxylin solution. The sections were incubated in hemat-
oxyline for 3 min and rinsed in water prior to exposure to eo-
sin for 2 min. After staining, the sections were dipped 10
times each in increasing concentrations of ethanol (70%,
90%, 95%, and 100%), dipped in xylene, and mounted using
Permount. Samples were observed at X200 and X400 high
power magnification using a light microscope.
2.6. Immunohistochemistry
To evaluate the tumor suppression effect of flavonoids, hu-
man tumor cells labeled with which PKH26 were injected into
Table 1 – Structures and mass spectral data of 14 flavonoids in C. aurantium L.
OR4O
OH O
R2
R1
R3
1: R1 = OH, R2 = R3 = H, R4 = neohesperidosyl
2: R1 = OCH3, R2 = OH, R3 = H, R4 = rutinosyl
3: R1 = OCH3, R2 = R3 = H, R4 = neohesperidosyl
O
OR5
R6
R7
R8
R4
R2
R1
R3
4: R1 = R2 = R5 = R7 = R8 = OCH3, R3 = R4 = R6 = H
5, 7, 14: R1 + R2 + R3 + R4 + R5 + R6 + R7 + R8 = 6CH3O + 2H
6: R1 = R3 = R5 = R6 = R7 = OCH3, R2 = R4 = R8 = H
8: R1 = R5 = R7 = R8 = OCH3, R2 = R3 = R4 = R6 = H
9: R1 = R3 = R5 = R6 = R7 = R8 = OCH3, R2 = R4 = H
10: R1 + R2 + R3 + R4 + R5 + R6 + R7 + R8 = 7CH3O + H
11: R1 = R3 = R5 = R6 = R7 = R8 = OCH3, R2 = H, R4 = OH
12: R1 = R5 = R6 = R7 = R8 = OCH3, R2 = R3 = R4 = H
13: R1 + R2 + R3 + R4 + R5 + R6 + R7 + R8 = OH + 5CH3O + 2H
Compound tR (min) [M + H]
+ Quantity ± SD (mg/kg)
Naringin (1) 16.46 581 299.2 ± 0.5
Hesperidin (2) 18.02 611 210.3 ± 1.3
Poncirin (3) 29.56 595 108.6 ± 1.1
Isosinensetin (4) 41.67 373 30.4 ± 0.1
Hexamethoxyflavone (5) 42.88 403 15.5 ± 0.1
Sinesetin (6) 43.40 373 19.7 ± 0.1
Hexamethoxyflavone (7) 44.60 403 23.6 ± 0.1
Tetramethyl–O–isoscutellarein (8) 45.91 343 35.6 ± 0.1
Nobiletin (9) 46.52 403 200.5 ± 0.1
Heptamethoxyflavone (10) 47.50 433 168.9 ± 1.3
3-Hydroxynobiletin (11) 48.91 419 28.7 ± 0.1
Tangeretin (12) 50.78 373 81.5 ± 0.1
Hydroxypentamethoxyflavone (13) 52.06 389 12.8 ± 0.1
Hexamethoxyflavone (14) 52.72 403 7.0 ± 0.1
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the lungs collected. PKH26 positive tumor cells were detected
by cryosection. Collected samples were immersed in 4% para-
formaldehyde for 48 h and then processed for paraffin wax
histology. Immunohistochemistry for p-p53 (1:500, Millipore)
and cleaved caspased-3 (1:500, Millipore) were performed
using rabbit monoclonal antibodies. Immunoreactivity was
visualized with avidin–biotin peroxidase reaction (PK-4001;
Vectastain ABC Kit; Vector Laboratories, Burlingame, CA,
USA) and Streptavidin Alexa fluor 488 conjugate (1:400, Molec-
ular Probes, Eugene, OR, USA). The peroxidase reaction was
developed using a 3,30-diaminobenzidine tetrahydrochloride
(D-5905; Sigma–Aldrich).2.7. Wound healing assay
Cell migration assay was performed using 12-well plates as
previously described (Park et al., 2012). A549 cells were seeded
into 6-well plates (2 · 105 cells/mL) and grown to 80% conflu-
ence for the assay. After removed the culture media, cells
were scraped with a 200 lL sterile pipette tip to make a
straight line. They were washed twice with cold PBS to re-
move debris and then incubated with complete RPMI 1640
media. A549 cells were treated with various concentration
of flavonoids (0, 10, 50, 150, and 250 lg/mL) for 24 h. Cell
migration into the wound area was photographed at the time
of 0 h and 48 h, respectively, for the wound closure analysis of
each treatment. The level of cell migration was measured
using a NIH Image software (Image J), and then it was ex-
pressed as a percentage of each control for the wound closure
space.2.8. Gelatin zymography
MMP-2 activity was measured by gelatin zymography (Park
et al., 2011). Briefly, A549 cells were incubated (1 · 105 cells/well)
and allowed to grow to confluence for 24 h and cultured in
RPMI 1640 with 10% FBS. The cells were washed with PBS
two times and incubated with various concentrations of
flavonoids (0, 10, 50, 150, and 250 lg/mL) in serum-free RPMI
1640 for 24 h. The supernatant was collected and mixed with
non-reducing sample buffer, then electrophoresed in 10%
SDS–polyacrylamide gel containing 0.1% (w/v) gelatin. After
the electrophoresis, gel was washed for 30 min twice with
2.5% Triton X-100 buffer and incubated for additional 20 h at
37 C for the enzymatic reaction of MMPs in zymographyTable 2 – List of the proteins differentially expressed in tail ve
recognized by MALDI-TOF/TOF/MS analysis.
Spot # Protein Accession #a Nomin
1 Ddx3x protein 219521150 73,426
2 Delta-aminolevulinic acid dehydratase 34328485 36,456
3 ANP32B protein 62471436 37,710
a Mascot search primary accession number.reaction buffer (200 mM NaCl, 10 mM CaCl2, 50 mM Tris–HCl,
pH 7.4). The gel was then stained with Coomassie blue R-
250 (0.12% Coomassie blue R-250, 50% methanol, 10% acetic
acid) and destained (methanol/acetic acid/water, 40:10:50,
v/v/v).2.9. Confocal scanning laser microscopic analysis
To examine cell morphological change, A549 cells were grown
on a thin microscope slide glasses. After 1 day in a 37 C incu-
bator, cells were treated with various concentrations of flavo-
noids (0, 10, 50, 150, and 250 lg/mL) in serum-free RPMI 1640
for 24 h. cells were visualized by Hoechst 33258 and phalloidin
staining. Fluorescence microscopy was performed using laser
scanning confocal microscopy.2.10. Terminal deoxynucleotidyltransferase-mediated dUTP
nick end-labeling (TUNEL) staining
TUNEL staining was performed using a DNA fragmentation
detection kit (QIA33; Calbiochem, San Diego, CA, USA),
according to the manufacturer’s instructions. Briefly, the sec-
tions were deparaffinized and permeabilized with Proteinase
K, and incubated with 3% hydrogen peroxide for 5 min, fol-
lowed by incubation with TdT enzyme solution for 90 min at
37 C. The reaction was terminated by incubation in stop
solution for 5 min. The peroxidase reaction was developed
with 3-3 0-diaminobenzidine tetrahydrochloride (D-5905; Sig-
ma–Aldrich). Counterstaining was performedwith hematoxy-
lin before mounting.
2.11. Western blot analysis
Total tissue lysates were prepared using lysis buffer (1 M Tris–
HCl [pH 8.0], 5 M NaCl, 1% NaN3, 10% sodium dodecyl sulfate,
10% NP-40, 0.5% C24H39NaO4). Cell lysates (50 lg protein) were
separated by 12% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) and then electrophoretically
transferred onto a polyvinylidene membrane. After blocking
in Tris buffered saline-Tween containing 5% skimmed milk
powder for 30 min, each membrane was incubated overnight
at 4 C with primary antibody against each target protein.
After washing five times, each membrane was incubated with
horseradish peroxidase-conjugated secondary antibody, and
protein levels were detected using an enhanced chemilumi-
nescence reagent (Anigen, Seoul, Korea).in injection mouse treated with C. aurantium L. extract, as
al mass (Mr) Matched peptide Sequence score Up/down
regulation
23 204 #
12 113 "
10 106 #
Fig. 2 – Flavonoids inhibit human lung cancer formation in NOD-SCID mice. NOD-SCID mice received a tail vein injection of
A549 cancer cells and were treated with flavonoids twice a week. Five weeks later, lungs were harvested and fixed with 4%
paraformaldehyde or lysed and subjected to Western blot analysis. (A) Microscopic appearance (H&E, 400·) showing normal,
A549 and flavonoids injected lung tissue. (B) Microscopic observationswere conducted at 400·magnification. (C) Western blot
analysis to quantify the levels of BAX and p-p53 protein. Data represent the mean ± SD of three replicates in independent
experiments. The asterisk (*) indicates a significant difference from the control group (*p < 0.05).
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Lung tissue protein was extracted using lysis buffer contain-
ing 7 M urea, 2 M thiourea, and 4% (w/v) CHAPS. Protein
(200 lg) was separated by isoelectric focusing (IEF) and 12%
SDS–PAGE. The protein spots in the analytical gels were visu-
alized by silver staining. The gel images were acquired using a
GS-800 scanner (Bio-Rad, Hercules, CA, USA) and analyzed
with Progenesis SameSpots 2D software, version 4.1 (Non-
linear Dynamics, Newcastle, UK) for detection of significant
protein spots. The spot intensities were normalized against
the total intensity of the gel. The replicate gels used to make
the matched set; a spot displaying a 2-fold intensity increase
or decrease was considered an up- or down-regulated protein,
respectively (Table 2). The selected protein spots were excised
manually from the 2-dimension electrophoresis (2-DE) gel for
protein identification. In-gel digestion of the selected protein
spots was performed as previously described (Shevchenko,
Wilm, Vorm, & Mann, 1996) with minor modifications. The
excised protein spots were proteolyzed in-gel with trypsin.
The tryptic fragment masses were detected by Matrix As-
sisted Laser Desorption Ionization Time of Flight/Time of
Flight Mass Spectrometry (MALDI-TOF/TOF MS) using a 4800Plus TOF-TOF mass spectrometer (Applied Biosystems) using
a 200 Hz ND:YAG laser operating at 355 nm. The 10 most
and least intense ions per MALDI spot with signal/noise ratios
exceeding 25 were selected for subsequent MS analysis in
1 kV mode using 800–1000 consecutive laser shots. The pro-
teins were identified by a Mascot-Peptide Mass Fingerprint
database search (http://www.matrixscience.com). The follow-
ing parameters were used for the database searches: taxon-
omy, mammalians; cleavage specificity, trypsin with one
missed cleavage allowed; Peptide tolerance of 100 ppm for
fragment ions; allowed modifications, Cys Carbamidomethyl
(fixed), oxidation of Met (variable). The MOWSE score was
considered to identify the correct protein from the mascot re-
sults list.2.13. Statistical analysis
Data are expressed as the mean ± standard deviation (SD) of a
minimum of three replicates independent experiments. Stu-
dent t-test was used for comparison using SPSS version 12.0
for Windows (SPSS, Chicago, IL, USA). The level of statistical
significant was set at p < 0.05.
Fig. 3 – Flavonoids inhibit human lung cancer metastasis in NOD-SCID mice. NOD-SCID mice received tail vein injection of
PKH26 labeled A549 cancer cells andwere treated with flavonoids twice a week. Five weeks later, the lung was harvested and
cryosectioned. (A) Microscopic observations were conducted at 400· magnification. PKH-labeled cells were counted in three
randomized fields. (B) Apoptosis was ascertained using a DNA fragmentation detection kit and apoptotic cells were counted
in three randomized fields. 3,3 0-Diaminobenzidine (DAB) labeled A549 cells were counted at 400· magnification in three
randomized fields. The data represent the mean ± SD; *p < 0.05 vs tail vein injection of A549 cancer cells alone.
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3.1. Flavonoids prevent A549 cell infiltration to alveoli
In control mice, H–E staining revealed typical polyhedral air
spaces and bronchiole structure in the lung. In mice injected
with A549 and treated with flavonoids, polyhedral air struc-
ture and no abnormal mass was observed. However, in the
A549 treatment group, the thickness of the alveoli wall and
abnormal mass in lung where air sac and bronchioles usually
placed in were detected in H–E stained samples (Fig. 2A). To
characterize the effect of flavonoids on A549 cells, we exam-
ined the distribution of A549 cells in lung samples using PKH-26 labeling. After A549 cell injection, the PKH-26 labeled cells
were significantly increased in lung tissue. Flavonoids treat-
ment markedly decreased the number of PKH-26 labeled cells
compared with A549 cells alone (Fig. 3A). These cell localiza-
tion experiments indicated that flavonoids prevent cell local-
ization and infiltration to lung tissue.
3.2. Flavonoids increase cleaved caspase-3 expression and
apoptotic cells lung tissue of mice injected with A549 cells
Expression of cleaved caspase-3 expression in lung tissue was
investigated. Immunohistochemistry revealed cleaved cas-
pase-3 positive reactivity in all groups. Red blood cells in lung
Fig. 4 – Representative 2-DE image pattern of the A549 tail vein injection mice lung in the absence or of flavonoids. The
samples were resolved by 2DE on nonlinear pH 3–10 IPG strips followed by separation on a 12% SDS–PAGE gel in the second
dimension. The proteins were visualized by silver nitrate staining.
Fig. 5 – Effects of flavonoids on the migration of A549 cells. (A) Confluent cultures of A549 cells were wounded with a
micropipette tip and incubated at 37 C for 24 h. Data are representative of three independent experiments. (B) A549 cells
were treated with flavonoids (0, 10, 50, 150 and 250 lg/mL) for 24 h and then subjected to gelatin zymography to analyze
MMP-2 activity. Atypical result of the densitometric analysis of the effect of flavonoids on the expression of MMP-2 is shown.
(C) A549 Cells were incubated with flavonoids for 24 h and fixed, stained with Hoechst 33258 and phalloidin stain.
Microscopic observations were conducted by confocal microscope (400·). The data represent the mean ± SD of cells analyzed
*p < 0.05 vs control group.
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creased cleaved caspase-3 positive reactivity was detected
in mice injected with A549 cells and treated with flavonoids,
compared with mice receiving either flavonoids or A549 alone
(Fig. 2B). The TUNEL assay also revealed a significant increase
in apoptotic cell bodies after treatment with flavonoids, com-
pared with A549 alone (Fig. 3B).
3.3. Flavonoids increase p-p53 and Bax expression in
lungs of mice injected with A549 cells
We assessed the relationship of cleaved caspase-3 expression
with the p-p53 and Bax signal pathways. Immunohistochem-
istry revealed that p-p53 positive cells were significantly in-
creased in mice treated with flavonoids, compared with
A549 alone (Fig. 3B). Likewise, p-p53 immunoblots established
that flavonoids induced apoptosis of A549 cells through p-p53
and Bax expression (Fig. 2C). The results supported the view
that flavonoids prevent A549 cell localization and induce
apoptosis through p-p53 and Bax activation.
3.4. Detection of apoptosis related proteins by 2-
Dimensional Electrophoresis (2-DE)
The differences of protein spots in lung tissue treated with
flavonoids were investigated by 2-DE in comparison with
A549 alone. The 2-DE maps of A549 alone and A549 injected
mice treated with flavonoids groups are shown in Fig. 4. Three
spots displayed marked and statistically significant altera-
tions (>2-fold or <2-fold, p < 0.05) in A549 injected mice trea-
ted or untreated with flavonoids. We focused on the
proteins related with apoptosis, such as DDX3X, Delta-amino-
levulinic acid dehydratase and ANP32B using MALDI-TOF/
TOF/MS (Table 2).
3.5. Flavonoids inhibits A549 cell motility
For scratch assay and quantitative assessment, the cells were
treated with flavonoids at various concentrations (0, 10, 50,
150 and 250 lg/mL) for 24 h. Flavonoids significantly inhibited
cell motility at 50, 150 and 250 lg/mL (Fig. 5A). A549 cells trea-
ted with these concentrations of flavonoids were not able to
migrate to the wounded area when compared to untreated
cells.
3.6. Flavonoids decreases MMP-2 expression in A549 cells
Metastasis is a multistep and complex process that includes
cell proliferation, ECM degradation and cell migration. The
MMP-2 protein is an ECM degrading enzyme, associated with
the invasive metastatic potential of various tumor and can-
cer cells. Zymography was performed to examine the activ-
ity of MMP-2 in A549 cells, which was treated with
flavonoids at various concentrations (0, 10, 50, 150 and
250 lg/mL) for 12 h. MMP-2 activity was significantly de-
creased in a dose-dependent manner (Fig. 5B). These results
support the suggestion that the anti-metastatic effect of
flavonoids is related to the inhibition of the degradation pro-
cesses of metastasis.3.7. Flavonoids induced nuclear cleavage and decomposed
filamentous actin in A549 cell
The actin cytoskeleton functions as a structural material sup-
porting the intracellular membrane from the inside. As
shown in Fig. 5C, flavonoids induced nuclear cleavage and
changed dynamics of the actin cytoskeleton in A549 cells.
These results indicate that flavonoids induced apoptosis by
the regulation of filamentous actin dynamics.
4. Discussion
Natural herbmedicines have been used for a long time in east-
ern Asia countries including Korea, China, and Japan (Seo
et al., 2013). Various studies have focused on their pharmaco-
logical benefits including their anti-cancer effect. However,
ethnopharmacology of traditional natural compounds has
suffered from a dearth of evidence-based studies (Mukherjee,
Venkatesh, & Ponnusankar, 2010). In this study, we isolated
themixture of 14 flavonoids in Korean C. aurantium L. and their
structures were characterized tentative using liquid chroma-
tography-tandom mass spectrometric data reported by us
(Kim et al., 2011). The major flavonoids (based on quantity)
were nobiletin, naringin, and hesperidin (Fig. 1 and Table 1).
The anti-cancer activity of these flavonoids has been reported
to involve cell cycle arrest and apoptosis in diverse cancer cell
lines (Chidambara Murthy, Jayaprakasha, Kumar, Rathore, &
Patil, 2011; Luo, Guan, & Zhou, 2008). Presently, flavonoids pre-
vented A549 cell migration and induced apoptosis in mouse
lung. Cleaved caspase-3 was significantly expressed in the
flavonoids treatment group and p-p53 was also significantly
increased, compared with A549 alone. These results suggest
an anti-cancer effect of flavonoids in A549 cells in vivo.
Metastasis is a successive series of events in which cells
that have detached from the tumor mass invade through the
basementmembrane and reach components of the circulation
system, such as blood vessels or lymph nodes, driving their
spread to distant sites in the body (Chiang & Massague, 2008;
Pantel & Brakenhoff, 2004). For this reason, multi-blood vessel
organs like liver or lung are the first target of metastasis. We
used a mouse tail vein injection metastasis model and suc-
cessfully identified cancer cells inmouse lung. Using thismod-
el, we demonstrated that the major effect of the flavonoids is
anti-localization and anti-metastasis in lung tissue. Decrease
of the total cancer cells labeled with PKH-26 supports the
anti-metastasis effect of flavonoids. Histochemical examina-
tion also showed that flavonoids could prevent tumor forma-
tion in lung tissue. Furthermore, we confirm that flavonoids
inhibited cell migration andMMP-2 protein expression in vitro.
Apoptosis is a normal form of cell death that plays a crit-
ical role in the homeostasis of the multicellular organisms
(Hsu & Hsueh, 2000). When a cell cannot overcome DNA dam-
age, cell repair ceases and the programmed cell death com-
mences. Induction of apoptosis in cancer cells is a good
anti-cancer strategy. Various synthetic anti-cancer drugs have
been implicated in this apoptotic effect including anti-angio-
genic and selective DNA damage. Appreciable success in can-
cer prevention has been achieved over the past few decades
(Kelloff, Sigman, & Greenwald, 1999). However, these anti-
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vere weight loss, vomiting, and hair loss. In contrast, natural
anti-cancer products are relatively non-toxic. Flavonoids iso-
lated from C. aurantium L. induce apoptosis in lung tissue cells
due to the increase of apoptotic proteins including cleaved
caspase-3, Bax, and p-p53. The tumor suppressor protein,
p53, is associated with cell growth inhibition and apoptosis
(Vousden, 2002). p53 regulates apoptosis through the Bax
and Bcl-2 proteins (Miyashita et al., 1994). Therefore, flavo-
noids originating from natural products may be excellent
candidate anti-cancer materials that are free of side-effects.
DDX3X is a DEAD box protein family member. DDX3X is an
enzyme that is encoded in humans by the DDX3X gene, and
which is characterized by the conserved D-E-A-D sequence
(Abdelhaleem, Maltais, & Wain, 2003). Several recent studies
indicated that DDX3X may promote cancer. DDX3X levels
are increased in breast cancer biogenesis and human hepato-
cellular carcinoma (Botlagunta et al., 2008; Huang et al., 2004).
Also, overexpression of DDX3 induces EMT and increases
motility in carcinogen treatment of MCF cells (Botlagunta
et al., 2008). Knockdown of DDX3X increases death receptor-
induced apoptosis via activation of caspase-3 (Sun, Song, Li,
Zhou, & Jope, 2008). ANP32B also known as APRIL (acidic pro-
tein rich in leucines) is a novel substrate for caspase-3 and
acts as a negative regulator for apoptosis via activation of cas-
pase-3 (Shen et al., 2010). For this reason, ANP43B protein is
highly expressed in several tumor tissues and promotes
growth of tumor cells in vivo (Hahne et al., 1998; Planelles
et al., 2004). Our results showed that DDX3X and ANP32B pro-
teins are decreased in mice injected with A549 cells and trea-
ted with flavonoids, compared with mice injected solely with
A549 cells. It has been previously reported that the ability of
cells to bind phalloidin is lost during apoptosis (Endresen,
Prytz, & Aarbakke, 1995). It was proposed, therefore, to com-
bine cell staining with fluoresceinated phalloidin with DNA
content analysis, to identify apoptotic cells and to reveal the
cell cycle distribution of both, apoptotic and nonapoptotic cell
populations. As shown in Fig. 5C, filamentous actin changed
significantly compared with control. These results support
the view that flavonoids isolated from C. aurantium L. induce
apoptosis and cell migration.
In conclusion, our results demonstrate that flavonoids iso-
lated from C. aurantium L. possess anti-cancer activity
through the regulation of apoptosis and cell migration. Flavo-
noids decreased PKH-26 labeled cells in the lungs of NOD/SCID
mice who received tail vein injection of PKH-26 labeled A549
cells. H–E staining revealed thickened alveoli and abnormal
mass in gas exchange areas in mice injected with A549 cells.
However, treatment with flavonoids or co-treatment with
A549 cells and flavonoids produced no significant changes
in H–E staining. Immunohistochemistry examination demon-
strated that flavonoids increased cleaved caspase-3 and p-p53
levels. Also, flavonoids increased p-p53 and BAX expression in
the lungs of mice injected with A549 cells. MALDI-TOF/TOF/
MS identified DDX3X and ANP32B as proteins that were de-
creased by flavonoids. Although detailed studies remain to
be done to examine the effect of flavonoids, this study
provides scientific support for the use of flavonoids iso-
lated from C. aurantium L. for the treatment of human lung
cancer.5. Conflicts of Interest
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